0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 324,000 324,000 324,000 xbrli:pure xbrli:shares iso4217:GBP 09919368 2023-04-01 2024-03-31 09919368 2024-03-31 09919368 2023-03-31 09919368 2022-01-01 2023-03-31 09919368 2023-03-31 09919368 2021-12-31 09919368 bus:Director1 2023-04-01 2024-03-31 09919368 core:WithinOneYear 2024-03-31 09919368 core:WithinOneYear 2023-03-31 09919368 core:ShareCapital 2024-03-31 09919368 core:ShareCapital 2023-03-31 09919368 core:RetainedEarningsAccumulatedLosses 2024-03-31 09919368 core:RetainedEarningsAccumulatedLosses 2023-03-31 09919368 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 09919368 core:Non-currentFinancialInstruments 2024-03-31 09919368 core:Non-currentFinancialInstruments 2023-03-31 09919368 bus:SmallEntities 2023-04-01 2024-03-31 09919368 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 09919368 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 09919368 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 09919368 bus:FullAccounts 2023-04-01 2024-03-31
COMPANY REGISTRATION NUMBER: 09919368
ACORNHEALTH & CARE LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
31 March 2024
ACORNHEALTH & CARE LIMITED
STATEMENT OF FINANCIAL POSITION
31 March 2024
2024
2023
Note
£
£
£
Fixed assets
Investments
4
324,000
324,000
Current assets
Debtors
5
302,439
437,694
Cash at bank and in hand
91,688
58,886
----------
----------
394,127
496,580
Creditors: amounts falling due within one year
6
469,739
529,000
----------
----------
Net current liabilities
75,612
32,420
----------
----------
Total assets less current liabilities
248,388
291,580
----------
----------
Net assets
248,388
291,580
----------
----------
Capital and reserves
Called up share capital
2
2
Profit and loss account
248,386
291,578
----------
----------
Shareholders funds
248,388
291,580
----------
----------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
ACORNHEALTH & CARE LIMITED
STATEMENT OF FINANCIAL POSITION (continued)
31 March 2024
These financial statements were approved by the board of directors and authorised for issue on 28 February 2025 , and are signed on behalf of the board by:
Ms K T Clark
Director
Company registration number: 09919368
ACORNHEALTH & CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 MARCH 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 168 Church Road, Hove, East Sussex, BN3 2DL.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The financial statements have been prepared under the going concern basis which assumes that the company will continue in operational existence for the foreseeable future. The validity of this assumption depends upon the continuing support of the creditors and on funding from other external sources. If the company were unable to continue in operational existence for the foreseeable future, adjustment would have to be made to reduce the balance sheet values of the assets to their recoverable amounts, and to provide for further liabilities that might arise. The director believes that it is appropriate for the financial statements to be prepared on the going concern basis.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Investments
Shares in group undertakings
£
Cost
At 1 April 2023 and 31 March 2024
324,000
----------
Impairment
At 1 April 2023 and 31 March 2024
----------
Carrying amount
At 31 March 2024
324,000
----------
At 31 March 2023
324,000
----------
5. Debtors
2024
2023
£
£
Other debtors
302,439
437,694
----------
----------
6. Creditors: amounts falling due within one year
2024
2023
£
£
Amounts owed to group undertakings and undertakings in which the company has a participating interest
428,299
428,300
Other creditors
41,440
100,700
----------
----------
469,739
529,000
----------
----------